Buscar en
Actas Urológicas Españolas (English Edition)
Toda la web
Inicio Actas Urológicas Españolas (English Edition) Treatment of stress urinary incontinence after prostatectomy with the adjustable...
Journal Information
Vol. 42. Issue 7.
Pages 473-482 (September 2018)
Download PDF
More article options
Vol. 42. Issue 7.
Pages 473-482 (September 2018)
Surgical Technique
Treatment of stress urinary incontinence after prostatectomy with the adjustable transobturator male system (ATOMS®) with preattached scrotal port
Tratamiento de la incontinencia urinaria de esfuerzo tras prostatectomía con el sistema masculino transobturador ajustable (ATOMS®) con puerto escrotal premontado
C. Esquinasa, I. Arancea,b, J. Pamplonab, A. Moragaa, J.F. Doradoc, J.C. Anguloa,b,
Corresponding author

Corresponding author.
a Servicio de Urología, Hospital Universitario de Getafe, Madrid, Spain
b Departamento Clínico, Facultad de Ciencias Biomédicas, Universidad Europea de Madrid, Laureate Universities, Getafe, Madrid, Spain
c Pertica S.L., Getafe, Madrid, Spain
This item has received
Article information
Full Text
Download PDF
Figures (5)
Show moreShow less
Tables (2)
Table 1. Preoperative, operative and postoperative data (n=60).
Table 2. Results described by the patient regarding incontinence (n=60).
Show moreShow less
Additional material (1)

Stress urinary incontinence (SUI) is a significant sequela of prostate cancer surgery. In this article, we present the surgical technique and safety and efficacy of the adjustable transobturator male system (ATOMS®) with preattached scrotal port.

Materials and method

An open prospective study was conducted at a university hospital with the main objective of changing the baseline condition after adjustment in the daily pad count and their wet weight (pad test). The secondary objectives were the quality-of-life assessment (International Consultation on Incontinence Questionnaire-Short Form [ICIQ-SF] and Incontinence Impact Questionnaire-7 [IIQ-7], baseline and after the adjustment), patient-perceived results (Patient Global Index [PGI] and Global Response Assessment [GRA] at 1 year) and assessment of complications according to Clavien-Dindo. The numerical values are expressed in median ± IQR.


We analyzed 60 consecutive patients with a follow-up of 21±22 months. The baseline pad-test was 465±450mL, and the pad-count was 5+3pads/day. The baseline SUI was mild (11.6% of patients), moderate (25%) and severe (63.3%). The operative time was 60±25min, the hospital stay was 1±0 days, and the visual analog scale of pain on day 1 after surgery was 0±1. The total filling was 16.5±7mL, and the number of refillings was 1±2. The pad-test and pad-count after the adjustment were 0±20mL and 0±1, respectively (both P<0.0001 compared with baseline). SUI disappeared (81.7%) or remained mild (11.7%), moderate (5%) or severe (1.6%). We observed a reduction in the ICIQ-SF (P<0.0001) and IIQ-7 scores (P=0.0003). Both continence (P=0.002) and satisfaction (P=0.03) were lower in the irradiated patients. Complications occurred in 11 cases (18.6%), 8 (13.5%) of which were grade I and 3 (5.1%) of which were grade 3. The treatment satisfaction rate was 91.7%, and the patient-perceived overall improvement at 1 year was highly pronounced (PGI-I score, 1±1; GRA, 6±1).


SUI treatment of men using third-generation ATOMS® is safe and effective in the short-term, even in patients with severe SUI. The rate of dry patients after the adjustment exceeded 80%, and the satisfaction rates exceeded 90%. The patients assessed this treatment highly positively.

Urinary incontinence
Adjustable transobturator male system (ATOMS®)

La incontinencia urinaria de esfuerzo (IUE) es una secuela importante del tratamiento quirúrgico del cáncer de próstata. Se presenta la técnica quirúrgica y se evalúa efectividad y seguridad del sistema masculino transobturador ajustable (ATOMS®) con puerto escrotal premontado.

Material y método

Estudio abierto prospectivo realizado en un hospital universitario. El objetivo principal fue cambio de situación basal tras ajuste en el recuento diario de compresas (pad-count) y su peso húmedo (pad-test). Los objetivos secundarios fueron evaluación de calidad de vida (ICIQ-SF e IIQ-7 basal y al ajuste), resultados percibidos por el paciente (PGI y GRA al año) y evaluación de complicaciones según Clavien-Dindo. Los valores numéricos se expresan en mediana ± RIC.


Se analizan 60 pacientes consecutivos con seguimiento de 21±22meses. El pad-test basal fue 465±450ml y pad-count 5±3 compresas/día. La IUE basal fue leve (11,6%), moderada (25%) y severa (63,3%). El tiempo operatorio fue 60±25min, la estancia hospitalaria 1±0 días y la EVA de dolor en día-1 postoperatorio 0±1. El llenado total fue 16,5±7ml y el número de rellenos 1±2. Pad-test y pad-count tras ajuste fueron 0±20ml y 0±1, respectivamente (ambos p<0,0001 respecto a basal). La IUE desapareció (81,7%) o se mantuvo leve (11,7%), moderada (5%) y severa (1,6%). Se objetivó reducción en ICIQ-SF (p<0,0001) e IIQ-7 (p=0,0003). Tanto la continencia (p=0,002) como la satisfacción (p=0,03) resultaron peores en pacientes irradiados. Sucedieron complicaciones en 11 casos (18,6%), siendo 8(13,5%) grado I y 3(5,1%) grado III. La tasa de satisfacción con el tratamiento fue 91,7% y la percepción de mejoría global percibida por el paciente al año fue muy marcada (score PGI-I 1±1 y GRA 6±1).


El tratamiento de la IUE masculina con ATOMS® tercera generación es seguro y eficaz a corto plazo, incluso en pacientes con IUE severa. La tasa de pacientes secos tras el ajuste supera el 80% y la tasa de satisfacción el 90%. Los pacientes valoran muy positivamente este tratamiento.

Palabras clave:
Incontinencia urinaria
Sistema transobturador ajustable masculino (ATOMS®)


These are the options to access the full texts of the publication Actas Urológicas Españolas (English Edition)

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe to

Actas Urológicas Españolas (English Edition)

Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Article options
Supplemental materials
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos